Ivy Cosmetics Corporation AI Stock Analysis
Want to see JP:4918 full AI Analyst Report?
Ivy Cosmetics Corporation (4918) AI Stock Analysis
Ivy Cosmetics Corporation
(TSE/TYO:4918)
Ivy Cosmetics achieves a strong overall score, driven primarily by an attractive valuation and exceptionally robust upside price momentum. The company benefits from an ironclad balance sheet and excellent cash flow generation, though this is partially tempered by ongoing weakness in top-line revenue growth.
Ivy Cosmetics Corporation (4918) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 3.00B
- Dividend Yield
- 3.14%
- Average Volume (3M)
- 27.02K
- Price to Earnings (P/E)
- 14.3
- Beta (1Y)
- 1.20
- Revenue Growth
- -5.54%
- EPS Growth
- -55.93%
- Country
- Japan
- Employees
- 179
- Sector
- General
- Sector Strength
- 55
- Industry
- Household & Personal Products
Ivy Cosmetics Corporation Business Overview & Revenue Model
Company Description
Ivy Cosmetics Corporation manufactures and distributes a comprehensive array of cosmetic products and beauty-enhancing supplements. Their extensive catalog includes fundamental skincare items like deep-penetrating beauty liquids, various lotions, emu...
Ivy Cosmetics Corporation Financial Statement Overview
Summary
The company demonstrates exceptional financial stability with an aggressively deleveraged balance sheet and robust free cash flow generation. However, the score is constrained by a persistent decline in top-line revenue despite improving net profit margins.
Income Statement
55NeutralBalance Sheet
85Very PositiveCash Flow
88Very Positive| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.64B | 2.93B | 2.71B | 2.94B | 3.53B |
| Gross Profit | 1.84B | 2.07B | 1.91B | 2.11B | 2.42B |
| EBITDA | 236.31M | 20.62M | 242.60M | -33.16M | 185.13M |
| Net Income | 164.53M | 43.01M | 160.31M | -384.61M | 40.38M |
Balance Sheet | |||||
| Total Assets | 3.64B | 3.57B | 3.57B | 3.85B | 4.49B |
| Cash, Cash Equivalents and Short-Term Investments | 1.04B | 577.94M | 208.73M | 247.67M | 129.38M |
| Total Debt | 278.01M | 211.34M | 451.69M | 1.05B | 1.18B |
| Total Liabilities | 1.00B | 1.10B | 1.33B | 1.87B | 2.22B |
| Stockholders Equity | 2.64B | 2.47B | 2.24B | 1.98B | 2.27B |
Cash Flow | |||||
| Free Cash Flow | 385.37M | 424.68M | 408.70M | 243.33M | -160.58M |
| Operating Cash Flow | 451.04M | 445.94M | 453.06M | 278.59M | -107.06M |
| Investing Cash Flow | -58.15M | -18.43M | 7.30M | -29.30M | 63.30M |
| Financing Cash Flow | 70.61M | -58.27M | -499.31M | -131.00M | 59.71M |
Ivy Cosmetics Corporation Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4918, the sentiment is Positive. The current price of 478.00 is above the 20-day moving average (MA) of 317.95, above the 50-day MA of 307.52, and above the 200-day MA of 322.01, indicating a bullish trend. The MACD of 20.27 indicates Negative momentum. The RSI at 90.85 is Negative, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4918.
Ivy Cosmetics Corporation Peers Comparison
Overall Rating
JP:491881Outperform
JP:492580Outperform
JP:492665Neutral
JP:492058Neutral
JP:492956Neutral
JP:493450Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 81Outperform | JPY 2.26B | 14.34 | ― | 3.14% | -5.54% | -55.93% | |
| 80Outperform | JPY 6.30B | 9.22 | ― | 2.40% | -2.92% | -25.96% | |
| 65Neutral | JPY 5.32B | 20.89 | ― | 1.61% | 1.51% | -18.54% | |
| 58Neutral | JPY 2.23B | 8.24 | ― | 2.82% | 9.96% | 2053.18% | |
| 56Neutral | JPY 5.92B | 36.88 | ― | 1.63% | -1.71% | 314.83% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 50Neutral | JPY 4.64B | 12.74 | ― | ― | -14.09% | -22.72% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4918 | Ivy Cosmetics Corporation | 478.00 | 163.98 | 52.22% | |
| JP:4920 | Nippon Shikizai, Inc. | 1055.00 | 2.57 | 0.24% | |
| JP:4925 | HABA Laboratories, Inc. | 1660.00 | 33.96 | 2.09% | |
| JP:4926 | C'BON COSMETICS Co., Ltd. | 1243.00 | 61.40 | 5.20% | |
| JP:4929 | ADJUVANT HOLDINGS CO., LTD. | 735.00 | -9.91 | -1.33% | |
| JP:4934 | Premier Anti-Aging Co., Ltd. | 532.00 | -166.00 | -23.78% |
Ivy Cosmetics Corporation Corporate Events
Ivy Cosmetics Reports September 2026 Sales and Profit Growth
The release identifies Ivy Cosmetics Corporation as a general-business company listed on Tokyo’s stock exchanges, but does not specify its industry, primary products or services, or market focus.For the September 2026 reporting period, net sales rose...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 14, 2026
